Avitar (AVTI) Stock Analysis & Winston Score

Avitar, Inc. is a small medical device company that makes diagnostic testing products. Its core product line has historically focused on oral fluid collection devices, which are used to collect saliva samples for drug testing and disease detection. Its main customers include healthcare providers, laboratories, and workplace drug-testing programs. The company earns revenue by selling its collection devices and related diagnostic products, primarily in the United States. Avitar is a very small company, with a market cap near zero, and it operates in a competitive space alongside larger diagnostics firms with greater resources. The deeply negative return on invested capital signals the company has struggled to generate profits from its assets, and the key risk it faces is whether it can scale revenue fast enough to achieve sustainable profitability before running out of financial runway.